Cleared Traditional

K091815 - SUPERCHECK 1 BLOOD GLUCOSE MONITORING SYSTEM, MODEL 6268

K091815 is an FDA 510(k) clearance for SUPERCHECK 1 BLOOD GLUCOSE MONITORING S..., manufactured by Biotest Medical Corp.. The device is a Class 2 Chemistry device with product code NBW cleared through the Traditional 510(k) pathway after a 151-day FDA review.

K091815 · Biotest Medical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2009
Decision
151d
Days
Class 2
Risk

K091815 is an FDA 510(k) clearance for the SUPERCHECK 1 BLOOD GLUCOSE MONITORING SYSTEM, MODEL 6268. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Biotest Medical Corp. (Fairfax, US). The FDA issued a Cleared decision on November 16, 2009 after a review of 151 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Biotest Medical Corp. devices

FDA 510(k) Submission Details - K091815

510(k) Number K091815 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2009
Decision Date November 16, 2009
Days to Decision 151 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
63d slower than avg
Panel avg: 88d · This submission: 151d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 423
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K091815.
DIDGET BLOOD GLUCOSE METER, MODEL 6181
K090628 · Bayer Healthcare, LLC · Dec 2009
LIPIDPRO SYSTEM
K090405 · Infopia Co, Ltd. · Dec 2009
GLUCO LAB AUTO CODING, MODEL IGM-0022
K091157 · Infopia Co, Ltd. · Nov 2009
EASYPLUS MINI MASTERDRIVER SELF MONITORING BLOOD GLUCOSE SYSTEM, MODEL EPS09009
K092887 · Eps Bio Technology Corp. · Oct 2009
EOCENE SYSTEM
K090712 · Infopia Co, Ltd. · Oct 2009
BLOOD GLUCOSE MONITORING SYSTEM, MODEL FORA G90/TD-4234
K091898 · Taidoc Technology Corporation · Sep 2009